Parkinson Disease, Secondary (diagnosis) < Parkinson Disease, Secondary (drug therapy) < Parkinson Disease, Secondary (epidemiology)

Facettes :

List of bibliographic references indexed by Parkinson Disease, Secondary (drug therapy)

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000885 (2013)	Maryka Quik ; Archana Mallela ; Jason Ly ; Danhui Zhang	Nicotine reduces established L-dopa-induced dyskinesias in a monkey model of Parkinson’s disease
001D47 (2010)	Seema Kalra [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] ; Hani T. S. Benamer [Royaume-Uni]	Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review
002A93 (2007)	Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Andrew Evans [Royaume-Uni] ; Flavia Fontes [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Svetoslav Gacinovic [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Durval Costa [Royaume-Uni, Portugal]	[123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
003862 (2005)	Anatol Kivi [Allemagne] ; Thomas Trottenberg [Allemagne] ; Andreas Kupsch [Allemagne] ; Michail Plotkin [Allemagne] ; Roland Felix [Allemagne] ; Ludwig Niehaus [Allemagne]	Levodopa‐responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra
004496 (2002)	Monica J. Ling [Australie] ; Arun Aggarwal [Australie] ; John G. L. Morris [Australie]	Dopa‐responsive parkinsonism secondary to right temporal lobe haemorrahage
004574 (2002)	Zhigao Huang [États-Unis] ; Michael Jacewicz [États-Unis] ; Ronald F. Pfeiffer [États-Unis]	Anticardiolipin antibody in vascular parkinsonism
004730 (2001)	Egberto R. Barbosa [Brésil] ; Maria D. Leiros Da Costa [Brésil] ; Luiz A. Bacheschi [Brésil] ; Milberto Scaff [Brésil] ; Claudia C. Leite [Brésil]	Parkinsonism after glycine‐derivate exposure
004736 (2001)	Nikolaos Scarmeas [États-Unis] ; David Eidelberg [États-Unis] ; Steven J. Frucht [États-Unis]	Oculogyric‐like crises in a 92‐year‐old woman with vascular Parkinsonism
004C74 (1999)	Gabriel Lera [Argentine] ; Jorge Zirulnik [Argentine]	Pilot study with clozapine in patients with HIV‐associated psychosis and drug‐induced parkinsonism
004C86 (1999)	Larry E. Davis [États-Unis] ; John C. Adair [États-Unis]	Parkinsonism from methanol poisoning: Benefit from treatment with anti‐parkinson drugs
004D19 (1999)	Nir Giladi [Israël] ; Eldad Melamed [Israël]	Levodopa therapy can ameliorate tetrabenazine‐induced parkinsonism
004D89 (1999)	Martin C. Prevett [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni]	Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis
004E10 (1999)	Elena Moro [Italie] ; Alberto Albanese [Italie, Suisse]	Apomorphine and levodopa challenge in patients with a focal midbrain lesion
005079 (1998)	Pierre J. Blanchet [États-Unis] ; Spyridon Konitsiotis [États-Unis] ; Thomas N. Chase [États-Unis]	Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
005194 (1998)	P. A. Lapchak [États-Unis]	A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
005271 (1997)	Federlein [Allemagne] ; Th. Postert [Allemagne] ; A. Allgeier [Allemagne] ; V. Hoffmann [Allemagne] ; D. Pöhlau [Allemagne] ; H. Przuntek [Allemagne]	Remitting parkinsonism as a symptom of multiple sclerosis and the associated magnetic resonance imaging findings
005293 (1997)	Turjanski [Royaume-Uni] ; Brian Pentland [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David J. Brooks [Royaume-Uni]	Parkinsonism associated with acute intracranial hematomas: An [18F]dopa positron‐emission tomography study
005594 (1996)	Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]	Postencephalitic stereotyped involuntary movements responsive to L‐Dopa
005673 (1996)	Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt [Allemagne] ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]	Computational analysis of open loop handwriting movements in Parkinson's disease: A rapid method to detect dopamimetic effects
005687 (1996)	P. D. Clouston ; C. L. Lim ; V. Fung ; C. Yiannikas ; Morris [Australie]	Brainstem myoclonus in a patient with non‐dopa‐responsive parkinsonism
005710 (1996)	Lance Smith [Royaume-Uni] ; Maria De Salvia [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	An appraisal of the antiparkinsonian activity of piribedil in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease, Secondary (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (drug therapy)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024